Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 141

1.

Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy.

Banerjee G, Ambler G, Keshavan A, Paterson RW, Foiani MS, Toombs J, Heslegrave A, Dickson JC, Fraioli F, Groves AM, Lunn MP, Fox NC, Zetterberg H, Schott JM, Werring DJ.

J Alzheimers Dis. 2020 Mar 11. doi: 10.3233/JAD-191254. [Epub ahead of print]

PMID:
32176643
2.

Airway tapering: an objective image biomarker for bronchiectasis.

Kuo W, Perez-Rovira A, Tiddens H, de Bruijne M; Normal Chest CT study group.

Eur Radiol. 2020 Feb 5. doi: 10.1007/s00330-019-06606-w. [Epub ahead of print]

PMID:
32025831
3.

Revalidation of PET/computed tomography criteria (Hopkins criteria) for the assessment of therapeutic response in lung cancer patients: inter-reader reliability, accuracy and survival outcomes.

Riyami KA, Nuaimi NA, Kliokyte R, Voo S, Thornton A, Bomanji J, Fraioli F.

Nucl Med Commun. 2020 Jan;41(1):18-25. doi: 10.1097/MNM.0000000000001114.

PMID:
31800507
4.

PET/MRI attenuation estimation in the lung: A review of past, present, and potential techniques.

Lillington J, Brusaferri L, Kläser K, Shmueli K, Neji R, Hutton BF, Fraioli F, Arridge S, Cardoso MJ, Ourselin S, Thielemans K, Atkinson D.

Med Phys. 2020 Feb;47(2):790-811. doi: 10.1002/mp.13943. Epub 2020 Jan 1. Review.

5.

Synergistic application of pulmonary 18F-FDG PET/HRCT and computer-based CT analysis with conventional severity measures to refine current risk stratification in idiopathic pulmonary fibrosis (IPF).

Fraioli F, Lyasheva M, Porter JC, Bomanji J, Shortman RI, Endozo R, Wan S, Bertoletti L, Machado M, Ganeshan B, Win T, Groves AM.

Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2023-2031. doi: 10.1007/s00259-019-04386-5. Epub 2019 Jul 8.

6.

Combined PET/MRI in brain glioma imaging.

Almansory KO, Fraioli F.

Br J Hosp Med (Lond). 2019 Jul 2;80(7):380-386. doi: 10.12968/hmed.2019.80.7.380. Review.

PMID:
31283392
7.

Correction to: Imaging of Bronchial Pathology in Antibody Deficiency: Data from the European Chest CT Group.

Schütz K, Alecsandru D, Grimbacher B, Haddock J, Bruining A, Driessen G, de Vries E, van Hagen PM, Hartmann I, Fraioli F, Milito C, Mitrevski M, Quinti I, Serra G, Kelleher P, Loebinger M, Litzman J, Postranecka V, Thon V, Babar J, Condliffe AM, Exley A, Kumararatne D, Screaton N, Jones A, Bondioni MP, Lougaris V, Plebani A, Soresina A, Sirignano C, Spadaro G, Galal N, Gonzalez-Granado LI, Dettmer S, Stirling R, Chapel H, Lucas M, Patel S, Farber CM, Meyts I, Banerjee AK, Hackett S, Hurst JR, Warnatz K, Gathmann B, Weidemann J, Berthold D, Baumann U; Chest CT in Antibody Deficiency Group.

J Clin Immunol. 2019 Feb;39(2):225-227. doi: 10.1007/s10875-019-00609-4.

PMID:
30905051
8.

Arterial Spin Labeling Reveals Disrupted Brain Networks and Functional Connectivity in Drug-Resistant Temporal Epilepsy.

Boscolo Galazzo I, Storti SF, Barnes A, De Blasi B, De Vita E, Koepp M, Duncan JS, Groves A, Pizzini FB, Menegaz G, Fraioli F.

Front Neuroinform. 2019 Mar 6;12:101. doi: 10.3389/fninf.2018.00101. eCollection 2018.

9.

Imaging of Bronchial Pathology in Antibody Deficiency: Data from the European Chest CT Group.

Schütz K, Alecsandru D, Grimbacher B, Haddock J, Bruining A, Driessen G, de Vries E, van Hagen PM, Hartmann I, Fraioli F, Milito C, Mitrevski M, Quinti I, Serra G, Kelleher P, Loebinger M, Litzman J, Postranecka V, Thon V, Babar J, Condliffe AM, Exley A, Kumararatne D, Screaton N, Jones A, Bondioni MP, Lougaris V, Plebani A, Soresina A, Sirignano C, Spadaro G, Galal N, Gonzalez-Granado LI, Dettmer S, Stirling R, Chapel H, Lucas M, Patel S, Farber CM, Meyts I, Banerjee AK, Hackett S, Hurst JR, Warnatz K, Gathmann B, Baumann U; Chest CT in Antibody Deficiency Group.

J Clin Immunol. 2019 Jan;39(1):45-54. doi: 10.1007/s10875-018-0577-9. Epub 2018 Dec 13. Erratum in: J Clin Immunol. 2019 Feb;39(2):225-227.

10.

PET imaging in glioma: techniques and current evidence.

Mansoor NM, Thust S, Militano V, Fraioli F.

Nucl Med Commun. 2018 Dec;39(12):1064-1080. doi: 10.1097/MNM.0000000000000914. Review.

PMID:
30303860
11.

Clinical Impact of Respiratory Motion Correction in Simultaneous PET/MR, Using a Joint PET/MR Predictive Motion Model.

Manber R, Thielemans K, Hutton BF, Wan S, Fraioli F, Barnes A, Ourselin S, Arridge S, Atkinson D.

J Nucl Med. 2018 Sep;59(9):1467-1473. doi: 10.2967/jnumed.117.191460. Epub 2018 Mar 9.

12.

Pulmonary 18F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF).

Win T, Screaton NJ, Porter JC, Ganeshan B, Maher TM, Fraioli F, Endozo R, Shortman RI, Hurrell L, Holman BF, Thielemans K, Rashidnasab A, Hutton BF, Lukey PT, Flynn A, Ell PJ, Groves AM.

Eur J Nucl Med Mol Imaging. 2018 May;45(5):806-815. doi: 10.1007/s00259-017-3917-8. Epub 2018 Jan 16.

13.

Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.

Abbosh C, Birkbak NJ, Wilson GA, Jamal-Hanjani M, Constantin T, Salari R, Le Quesne J, Moore DA, Veeriah S, Rosenthal R, Marafioti T, Kirkizlar E, Watkins TBK, McGranahan N, Ward S, Martinson L, Riley J, Fraioli F, Al Bakir M, Grönroos E, Zambrana F, Endozo R, Bi WL, Fennessy FM, Sponer N, Johnson D, Laycock J, Shafi S, Czyzewska-Khan J, Rowan A, Chambers T, Matthews N, Turajlic S, Hiley C, Lee SM, Forster MD, Ahmad T, Falzon M, Borg E, Lawrence D, Hayward M, Kolvekar S, Panagiotopoulos N, Janes SM, Thakrar R, Ahmed A, Blackhall F, Summers Y, Hafez D, Naik A, Ganguly A, Kareht S, Shah R, Joseph L, Quinn AM, Crosbie PA, Naidu B, Middleton G, Langman G, Trotter S, Nicolson M, Remmen H, Kerr K, Chetty M, Gomersall L, Fennell DA, Nakas A, Rathinam S, Anand G, Khan S, Russell P, Ezhil V, Ismail B, Irvin-Sellers M, Prakash V, Lester JF, Kornaszewska M, Attanoos R, Adams H, Davies H, Oukrif D, Akarca AU, Hartley JA, Lowe HL, Lock S, Iles N, Bell H, Ngai Y, Elgar G, Szallasi Z, Schwarz RF, Herrero J, Stewart A, Quezada SA, Peggs KS, Van Loo P, Dive C, Lin CJ, Rabinowitz M, Aerts HJWL, Hackshaw A, Shaw JA, Zimmermann BG, Swanton C.

Nature. 2018 Feb 8;554(7691):264. doi: 10.1038/nature25161. Epub 2017 Dec 20.

PMID:
29258292
14.

Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.

Abbosh C, Birkbak NJ, Wilson GA, Jamal-Hanjani M, Constantin T, Salari R, Le Quesne J, Moore DA, Veeriah S, Rosenthal R, Marafioti T, Kirkizlar E, Watkins TBK, McGranahan N, Ward S, Martinson L, Riley J, Fraioli F, Al Bakir M, Grönroos E, Zambrana F, Endozo R, Bi WL, Fennessy FM, Sponer N, Johnson D, Laycock J, Shafi S, Czyzewska-Khan J, Rowan A, Chambers T, Matthews N, Turajlic S, Hiley C, Lee SM, Forster MD, Ahmad T, Falzon M, Borg E, Lawrence D, Hayward M, Kolvekar S, Panagiotopoulos N, Janes SM, Thakrar R, Ahmed A, Blackhall F, Summers Y, Hafez D, Naik A, Ganguly A, Kareht S, Shah R, Joseph L, Marie Quinn A, Crosbie PA, Naidu B, Middleton G, Langman G, Trotter S, Nicolson M, Remmen H, Kerr K, Chetty M, Gomersall L, Fennell DA, Nakas A, Rathinam S, Anand G, Khan S, Russell P, Ezhil V, Ismail B, Irvin-Sellers M, Prakash V, Lester JF, Kornaszewska M, Attanoos R, Adams H, Davies H, Oukrif D, Akarca AU, Hartley JA, Lowe HL, Lock S, Iles N, Bell H, Ngai Y, Elgar G, Szallasi Z, Schwarz RF, Herrero J, Stewart A, Quezada SA, Peggs KS, Van Loo P, Dive C, Lin CJ, Rabinowitz M, Aerts HJWL, Hackshaw A, Shaw JA, Zimmermann BG; TRACERx consortium; PEACE consortium, Swanton C.

Nature. 2017 Apr 26;545(7655):446-451. doi: 10.1038/nature22364. Erratum in: Nature. 2017 Dec 20;:.

15.

Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in Lymphoma.

Afaq A, Fraioli F, Sidhu H, Wan S, Punwani S, Chen SH, Akin O, Linch D, Ardeshna K, Lambert J, Miles K, Groves A, Kayani I.

Clin Nucl Med. 2017 Jan;42(1):e1-e7.

16.

Cerebral metabolism and perfusion in MR-negative individuals with refractory focal epilepsy assessed by simultaneous acquisition of (18)F-FDG PET and arterial spin labeling.

Boscolo Galazzo I, Mattoli MV, Pizzini FB, De Vita E, Barnes A, Duncan JS, Jäger HR, Golay X, Bomanji JB, Koepp M, Groves AM, Fraioli F.

Neuroimage Clin. 2016 Apr 12;11:648-657. doi: 10.1016/j.nicl.2016.04.005. eCollection 2016.

17.

Positive (18)Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography Predicts Preinvasive Endobronchial Lesion Progression to Invasive Cancer.

Fraioli F, Kayani I, Smith LJ, Bomanji JB, Capitanio A, Falzon M, Carroll B, Navani N, Brown J, Thakrar RM, George PJ, Groves AM, Janes SM.

Am J Respir Crit Care Med. 2016 Mar 1;193(5):576-9. doi: 10.1164/rccm.201508-1617LE. No abstract available.

18.

Lung magnetic resonance imaging with diffusion weighted imaging provides regional structural as well as functional information without radiation exposure in primary antibody deficiencies.

Milito C, Pulvirenti F, Serra G, Valente M, Pesce AM, Granata G, Catalano C, Fraioli F, Quinti I.

J Clin Immunol. 2015 Jul;35(5):491-500. doi: 10.1007/s10875-015-0172-2. Epub 2015 Jun 12.

19.

PET/MRI in the Upper Abdomen.

Gavra M, Syed R, Fraioli F, Afaq A, Bomanji J.

Semin Nucl Med. 2015 Jul;45(4):282-92. doi: 10.1053/j.semnuclmed.2015.03.002. Review.

PMID:
26050656
20.

Assessment of CF lung disease using motion corrected PROPELLER MRI: a comparison with CT.

Ciet P, Serra G, Bertolo S, Spronk S, Ros M, Fraioli F, Quattrucci S, Assael MB, Catalano C, Pomerri F, Tiddens HA, Morana G.

Eur Radiol. 2016 Mar;26(3):780-7. doi: 10.1007/s00330-015-3850-9. Epub 2015 May 30.

PMID:
26024847

Supplemental Content

Loading ...
Support Center